Karl Herholz

Active 1984–2025

Also published as
Karl HERHOLZ
131
Papers
22,211
Citations
89
h-index
126
i10-index

Citations

Citations per year for Karl Herholz1967: 1 citations1985: 7 citations1986: 7 citations1987: 14 citations1988: 5 citations1989: 8 citations1990: 8 citations1991: 15 citations1992: 36 citations1993: 23 citations1994: 36 citations1995: 41 citations1996: 59 citations1997: 75 citations1998: 80 citations1999: 83 citations2000: 100 citations2001: 102 citations2002: 107 citations2003: 148 citations2004: 187 citations2005: 211 citations2006: 201 citations2007: 256 citations2008: 250 citations2009: 304 citations2010: 236 citations2011: 269 citations2012: 280 citations2013: 228 citations2014: 274 citations2015: 208 citations2016: 186 citations2017: 181 citations2018: 188 citations2019: 516 citations2020: 482 citations2021: 517 citations2022: 418 citations2023: 301 citations2024: 391 citations2025: 183 citations2026: 7 citations1968–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,313 citing papers, 23.5% of this breakdownGermany: 956 citing papers, 9.7% of this breakdownUnited Kingdom: 826 citing papers, 8.4% of this breakdownItaly: 595 citing papers, 6% of this breakdownChina: 498 citing papers, 5.1% of this breakdownFrance: 498 citing papers, 5.1% of this breakdownNetherlands: 423 citing papers, 4.3% of this breakdownCanada: 351 citing papers, 3.6% of this breakdownSweden: 319 citing papers, 3.2% of this breakdownSpain: 315 citing papers, 3.2% of this breakdownAustralia: 265 citing papers, 2.7% of this breakdownSwitzerland: 263 citing papers, 2.7% of this breakdown
0%23.5%Other 22.5%

Fields

  • Medicine66.6%
  • Neuroscience19.8%
  • Biochemistry, Genetics and Molecular Biology6.7%
  • Computer Science2.4%
  • Psychology1.4%
  • Engineering0.6%
  • Other2.5%

Topics

  • Alzheimer's disease research and treatments8.5%
  • Dementia and Cognitive Impairment Research8.3%
  • Functional Brain Connectivity Studies3.9%
  • Medical Imaging Techniques and Applications3.9%
  • Parkinson's Disease Mechanisms and Treatments3.7%
  • Neurological disorders and treatments3.1%
  • Other68.6%

Coauthors

All papers

Open in search
  1. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander Drzezga - The Lancet Neurology 2020 cited by 531

  2. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Niklas Mattsson, José Luís Molinuevo, Andreas U. Monsch, Urs P. Mosimann, Alessandro Padovani, Agnese Picco, Corinna Porteri, Osman Ratib, Laure Saint‐Aubert, Charles Scerri, Philip Scheltens, Jonathan M. Schott, Ida Sonni, Stefan Teipel, Paolo Vineis, Pieter Jelle Visser, Yutaka Yasui, Bengt Winblad - The Lancet Neurology 2017 cited by 628

  3. Astrocyte Biomarkers in Alzheimer’s Disease

    Authors: , , , , , - Trends in Molecular Medicine 2019 cited by 356

  4. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations

    Authors: , , , , , , , - European Journal of Cancer 1999 cited by 1,718

  5. Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias

    Authors: , , , , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2008 cited by 723

  6. Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Craig Ritchie, Símone Rossi, Emiliano Santarnecchi, Olaf Sporns, Steven Verdooner, Andrea Vergallo, Nicolas Villain, Erfan Younesi, Francesco Garaci, Simone Lista - Journal of Alzheimer s Disease 2018 cited by 176

  7. Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aurélie Kas, Foudil Lamari, Marcel Lévy, Simone Lista, Christiane Metzinger, Fanny Mochel, Francis Nyasse, Catherine Poisson, Marie‐Claude Potier, Marie Revillon, Antonio Santos, Katia Santos Andrade, Marine Sole, Mohmed Surtee, Michel Thiebaut de Schotten, Andrea Vergallo, Nadjia Younsi, Mohammad Afshar, Lisi Flores Aguilar, Leyla Akman‐Anderson, Joaquín Arenas, Jesús Ávila, Claudio Babiloni, Filippo Baldacci, Richard Batrla, Norbert Benda, Keith L. Black, Arun L.W. Bokde, Ubaldo Bonuccelli, Karl Broich, Francesco Cacciola, Filippo Caraci, Giuseppe Caruso, Juan Carlos Martínez‐Castrillo, Enrica Cavedo, Roberto Ceravolo, Patrizia A. Chiesa, Massimo Corbo, Jean‐Christophe Corvol, Augusto Claudio Cuello, Jeffrey L. Cummings, Herman Depypere, Bruno Dubois, Andrea Duggento, Enzo Emanuele, Valentina Escott‐Price, Howard J. Federoff, Maria Teresa Ferretti, Massimo Fiandaca, Richard A. Frank, Francesco Garaci, Hugo Geerts, Ezio Giacobini, Filippo Sean Giorgi, Edward J. Goetzl, Manuela Graziani, Marion Haberkamp, Marie-Odile Habert, Britta Hänisch, Harald Hampel, Karl Herholz, Félix Hernández, Bruno P. Imbimbo, Dimitrios Kapogiannis, Eric Karran, Steven J. Kiddle, Seung Hyun Kim, Yosef Koronyo, Maya Koronyo‐Hamaoui, Todd Langevin and 31 more - Neurobiology of Aging 2020 cited by 47

  8. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

    Authors: , , , , , , , , , , , , , - Nature Reviews Drug Discovery 2010 cited by 631

  9. β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roberto Ceravolo, Patrizia A. Chiesa, Massimo Corbo, Jean‐Christophe Corvol, Augusto Claudio Cuello, Jeffrey L. Cummings, Herman Depypere, Bruno Dubois, Andrea Duggento, Enzo Emanuele, Valentina Escott‐Price, Howard J. Federoff, Maria Teresa Ferretti, Massimo S. Fiandaca, Richard Frank, Francesco Garaci, Hugo Geerts, Ezio Giacobini, Filippo Sean Giorgi, Edward J. Goetzl, Manuela Graziani, Marion Haberkamp, Marie‐Odile Habert, Britta Hänisch, Harald Hampel, Karl Herholz, Félix Hernández, Bruno P. Imbimbo, Dimitrios Kapogiannis, Eric Karran, Steven J. Kiddle, Seung Hyun Kim, Yosef Koronyo, Maya Koronyo‐Hamaoui, Todd Langevin, Stéphane Lehéricy, Pablo Lemercier, Simone Lista, Francisco Llavero, Jean Lorenceau, Alejandro Lucía, Dalila Mango, Mark Mapstone, Christian Néri, Robert Nisticò, Sid E. O’Bryant, Giovanni Palermo, George Perry, Craig Ritchie, Símone Rossi, Amira Saidi, Emiliano Santarnecchi, Lon S. Schneider, Olaf Sporns, Nicola Toschi, Pedro L. Valenzuela, Bruno Vellas, Steven R. Verdooner, Andrea Vergallo, Nicolas Villain, Kelly Virecoulon Giudici, Mark Watling, Lindsay A. Welikovitch, Janet Woodcock, Erfan Younesi, José L. Zugaza - Alzheimer s Research & Therapy 2020 cited by 40

  10. Brain Tumors

    Authors: , , , - Seminars in Nuclear Medicine 2012 cited by 164

  11. Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - NeuroImage 2002 cited by 836

  12. Imaging markers for Alzheimer disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2013 cited by 223

  13. The EMIF-AD PreclinAD study: study design and baseline cohort overview

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s Research & Therapy 2018 cited by 88

  14. Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer’s disease: metabolic basis for dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Scientific Reports 2016 cited by 87

  15. Dementia in Parkinson disease

    Authors: , , , , , , , , - Neurology 2005 cited by 384

  16. Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature

    Authors: , , , , - Journal of Nuclear Medicine 2011 cited by 284

  17. Brain inflammation is induced by co-morbidities and risk factors for stroke

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Brain Behavior and Immunity 2011 cited by 206

  18. Lithium as a Treatment for Alzheimer’s Disease: The Systems Pharmacology Perspective

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Augusto Claudio CUELLO, Jeffrey L. CUMMINGS, Herman DEPYPERE, Bruno DUBOIS, Andrea DUGGENTO, Enzo EMANUELE, Valentina ESCOTT-PRICE, Howard FEDEROFF, Maria Teresa FERRETTI, Massimo FIANDACA, Richard A. FRANK, Francesco GARACI, Hugo GEERTS, Filippo S. GIORGI, Edward J. GOETZL, Manuela GRAZIANI, Marion HABERKAMP, Marie-Odile HABERT, Harald HAMPEL, Karl HERHOLZ, Felix HERNANDEZ, Dimitrios KAPOGIANNIS, Eric KARRAN, Steven J. KIDDLE, Seung H. KIM, Yosef KORONYO, Maya KORONYO-HAMAOUI, Todd LANGEVIN, Stéphane LEHÉRICY, Alejandro LUCÍA, Simone LISTA, Jean LORENCEAU, Dalila MANGO, Mark MAPSTONE, Christian NERI, Robert NISTICÓ, Sid E. O’BRYANT, Giovanni PALERMO, George PERRY, Craig RITCHIE, Simone ROSSI, Amira SAIDI, Emiliano SANTARNECCHI, Lon S. SCHNEIDER, Olaf SPORNS, Nicola TOSCHI, Steven R. VERDOONER, Andrea VERGALLO, Nicolas VILLAIN, Lindsay A. WELIKOVITCH, Janet WOODCOCK, Erfan YOUNESI - Journal of Alzheimer s Disease 2019 cited by 65

  19. Education and occupation as proxies for reserve in aMCI converters and AD

    Authors: , , , , , , , , , , - Neurology 2008 cited by 218

  20. Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

    Authors: , , , , , , , - Neurobiology of Aging 2017 cited by 95

  21. MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marcel Lévy, Simone Lista, Christiane Metzinger, Fanny Mochel, Francis Nyasse, Catherine Poisson, Marie‐Claude Potier, Marie Revillon, Antonio Santos, Katia Santos Andrade, Marine Sole, Mohmed Surtee, Michel Thiebaut de Schotten, Andrea Vergallo, Nadjia Younsi, Bruno Dubois, the Alzheimer Precision Medicine Initiative (APMI), Mohammad Afshar, Lisi Flores Aguilar, Leyla Akman‐Anderson, Joaquín Arenas, Jesús Ávila, Claudio Babiloni, Filippo Baldacci, Richard Batrla, Norbert Benda, Keith L. Black, Arun L.W. Bokde, Ubaldo Bonuccelli, Karl Broich, Francesco Cacciola, Filippo Caraci, Giuseppe Caruso, Juan Carlos Martínez‐Castrillo, Enrica Cavedo, Roberto Ceravolo, Patrizia A. Chiesa, Massimo Corbo, Jean‐Christophe Corvol, Augusto Claudio Cuello, Jeffrey L. Cummings, Herman Depypere, Andrea Duggento, Enzo Emanuele, Valentina Escott-Price, Howard Federoff, Maria Teresa Ferretti, Massimo Fiandaca, Richard Frank, Francesco Garaci, Hugo Geerts, Ezio Giacobini, Filippo Sean Giorgi, Edward J. Goetzl, Manuela Graziani, Marion Haberkamp, Britta Hänisch, Karl Herholz, Félix Hernández, Bruno P. Imbimbo, Dimitrios Kapogiannis, Eric Karran, Steven J. Kiddle, Seung Hyun Kim, Yosef Koronyo, Maya Koronyo‐Hamaoui, Todd Langevin, Stéphane Lehéricy, Francisco Llavero, Jean Lorenceau and 25 more - Translational Psychiatry 2021 cited by 32

  22. Clinical amyloid imaging in Alzheimer's disease

    Authors: , - The Lancet Neurology 2011 cited by 241

  23. 18F-FDG PET and Perfusion SPECT in the Diagnosis of Alzheimer and Lewy Body Dementias

    Authors: , , , , , , , , , - Journal of Nuclear Medicine 2014 cited by 193

  24. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

    Authors: , , , , , , , , , , , , - Neurobiology of Aging 2017 cited by 79